Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-MUC1C-ALLO1, a Fully Allogeneic CAR-T Targeting Multiple Solid Tumors
Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to […]
Lannett Announces Submission of Investigational New Drug (IND) Application for Biosimilar Insulin Glargine
Lannett Company, Inc. (NYSE: LCI) today announced the submission of an Investigational New Drug (IND) application […]
Vault Health Ready to Meet Nation's COVID Testing Needs, Capable of Detecting Omicron
As positivity rates surge across the country, and public health officials worry about the supply […]
Owkin and Amgen Use AI to Improve Cardiovascular Risk Prediction
AI startup Owkin and Amgen have announced the results of a three-year project to use […]
Argobio and GeneCode Partner on Parkinson’s Disease in Argobio’s First Announced Research Agreement
Argobio and GeneCode have announced their collaboration to develop small molecule Glial cell line – Derived […]
NHS Strikes Deal to Make PKU Drug Available For All
The NHS is set to make a drug for the rare, debilitating disorder phenylketonuria (PKU) […]
Genoscience Pharma Licenses GNS561, its PPT-1 Inhibitor, to GENFIT in Cholangiocarcinoma Indication in US/Canada and Europe
Genoscience Pharma, a clinical stage biotechnology company developing unique lysosomotropic drug candidates for the treatment of […]
Evusheld Long-acting Antibody Combination Retains Neutralising Activity Against Omicron Variant in Independent FDA Study
AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination for the prevention of COVID-19, retained neutralising […]
Metrion Biosciences and Bioqube Ventures Collaborate on Venture Creation Project to Identify Novel Ion Channel Inhibitors for Autoimmune Diseases
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, and Bioqube Ventures […]
BCI Pharma Enters into Strategic Partnership with Mithra to Identify Novel Therapy for Endometriosis and Cancer in Women
BCI Pharma, owner of a proprietary kinase technology platform, and Mithra, a global independent pharmaceutical group, today announce […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more